The myocardial protection of polarizing cardioplegia combined with delta-opioid receptor agonist in swine.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21619990.
- Also identified by DOI 10.1016/j.athoracsur.2011.02.069.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to determine whether polarized arrest using adenosine/lidocaine cold crystalloid cardioplegia in combination with the hibernation inductor δ-opioid receptor agonist pentazocine would give satisfactory myocardial protection rather than using depolarized supranormal potassium cardioplegia, supranormal potassium cardioplegia with pentazocine, or adenosine/lidocaine cardioplegia. Twenty pigs were randomly divided into four groups (n=5 each) to receive the four types of cold crystalloid cardioplegia with an aortic cross-clamp time of 1 hour. Hemodynamic data were continuously measured, as was the left ventricular end-diastolic pressure (LVEDP), left ventricular end-systolic pressure (LVESP), plus or minus derivative of change in diastolic pressure over time (±dp/dt), cardiac output, pulmonary artery pressure, pulmonary capillary wedge pressure, cardiac troponin I, and left ventricular ultrastructure. Both the adenosine/lidocaine/pentazocine group and the adenosine/lidocaine group got significantly better results than the hyperkalemic and hyperkalemic pentazocine groups in improving hemodynamic values, pulmonary capillary wedge pressure, LVEDP, LVESP, ±dp/dt, cardiac output, cardiac troponin I values, and left ventricular ultrastructure. There were no statistical differences between the adenosine/lidocaine/pentazocine group and the adenosine/lidocaine group at 1 hour after cross-clamp removal; but at 2 hours after cross-clamp removal, the adenosine/lidocaine/pentazocine group stands out (LVEDP 3.3±0.5, LVESP 122.5±18.9, +dp/dt 2.9±0.1, -dp/dt 2.0±0.6, cardiac output 2.6±0.4, and troponin I 4.9±0.5), with significant differences from the adenosine/lidocaine group (LVEDP 5.8±1.0, LVESP 98.5±10.1, +dp/dt 2.5±0.2, -dp/dt 1.0±0.2, cardiac output 2.2±0.2, troponin I 8.2±0.8; p<0.05). The defibrillation rate was largely decreased after the cross-clamp was released in the group containing pentazocine in cardioplegia. Adenosine/lidocaine/pentazocine cold crystalloid cardioplegia gave satisfactory cardiac arrest and better myocardial protection than the other three groups, especially with regard to improving prolonged postoperative cardiac function.
Medical subject headings
- Heart
- Heart Arrest, Induced
- Receptors, Opioid, delta